Stock-Based Compensation for AbbVie (ABBV)
Stock-Based Compensation for AbbVie (ABBV): headline value $955.00M · YoY +4.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingStock-Based CompensationSwitch metric
Latest period
$955.00M
YoY change
+4.8%
5Y CAGR
+4.9%
Peak year (2025)
$955.00M
Latest annual
$955.00M
Stock-Based Compensation history chart for AbbVie (ABBV) from 2009 to 2025
Stock-Based Compensation history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $955.00M | +4.8% | ||
| 2024 | $911.00M | +22.0% | ||
| 2023 | $747.00M | +11.3% | ||
| 2022 | $671.00M | -3.0% | ||
| 2021 | $692.00M | -8.1% | ||
| 2020 | $753.00M | +75.1% | ||
| 2019 | $430.00M | +2.1% | ||
| 2018 | $421.00M | +15.3% | ||
| 2017 | $365.00M | +3.4% | ||
| 2016 | $353.00M | +25.2% | ||
| 2015 | $282.00M | +17.0% | ||
| 2014 | $241.00M | +13.7% | ||
| 2013 | $212.00M | +13.4% | ||
| 2012 | $187.00M | +14.7% | ||
| 2011 | $162.98M | -2.4% | ||
| 2010 | $167.00M | +6.6% | ||
| 2009 | $156.72M | — |
Stock-Based Compensation values are taken from AbbVie's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual stock-based compensation for AbbVie (ABBV) came in at $955.00M – edged up 4.8% year-over-year.
Over 2020–2025 (5 years), AbbVie stock-based compensation expanded at a +4.9% compound annual rate, with the latest reading among the more recent periods of the dataset.
Across the available history, stock-based compensation reached its high of $955.00M in 2025 and its low of $156.72M in 2009.
AbbVie (ABBV) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of $0.
AbbVie Stock-Based Compensation by Year
AbbVie Stock-Based Compensation 2025: $955.00M
AbbVie stock-based compensation in 2025 was $955.00M, edged up 4.8% from 2024. This figure represents the highest annual value in the available history.
AbbVie Stock-Based Compensation 2024: $911.00M
AbbVie stock-based compensation in 2024 was $911.00M, grew 22.0% from 2023.
AbbVie Stock-Based Compensation 2023: $747.00M
AbbVie stock-based compensation in 2023 was $747.00M, grew 11.3% from 2022.
AbbVie Stock-Based Compensation 2022: $671.00M
AbbVie stock-based compensation in 2022 was $671.00M, edged down 3.0% below 2021.
AbbVie Stock-Based Compensation 2021: $692.00M
AbbVie stock-based compensation in 2021 was $692.00M.
See more financial history for AbbVie (ABBV).
Sector peers — Stock-Based Compensation
Companies in the same sector as AbbVie, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $0 | Healthcare |
Frequently asked questions
What is AbbVie's stock-based compensation?
Latest reported stock-based compensation for AbbVie (ABBV) is $955.00M (period ending December 31, 2025).
How has AbbVie stock-based compensation changed year-over-year?
AbbVie (ABBV) stock-based compensation changed +4.8% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie stock-based compensation?
AbbVie (ABBV) stock-based compensation compound annual growth rate is +4.9% over the most recent 5 years available.
When did AbbVie stock-based compensation hit its highest annual value?
AbbVie stock-based compensation reached its highest annual value of $955.00M in 2025.
What was AbbVie stock-based compensation in 2024?
AbbVie (ABBV) stock-based compensation in 2024 was $911.00M.
What was AbbVie stock-based compensation in 2025?
AbbVie (ABBV) stock-based compensation in 2025 was $955.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.